GERON CORP's ticker is GERN and the CUSIP is 374163103. A total of 156 filers reported holding GERON CORP in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,229,891 | -29.0% | 10,012,902 | +7.5% | 0.00% | -25.0% |
| Q2 2023 | $29,902,435 | +70.5% | 9,315,398 | +15.3% | 0.00% | +100.0% |
| Q1 2023 | $17,537,620 | +112674.9% | 8,081,850 | +25.8% | 0.00% | 0.0% |
| Q4 2022 | $15,551 | -99.9% | 6,426,085 | +4.0% | 0.00% | 0.0% |
| Q3 2022 | $14,454,000 | +47.3% | 6,177,008 | -2.4% | 0.00% | +100.0% |
| Q2 2022 | $9,814,000 | +25.8% | 6,331,897 | +10.4% | 0.00% | 0.0% |
| Q1 2022 | $7,799,000 | +16.9% | 5,735,069 | +4.8% | 0.00% | 0.0% |
| Q4 2021 | $6,674,000 | -12.9% | 5,470,619 | -2.2% | 0.00% | 0.0% |
| Q3 2021 | $7,660,000 | +4.9% | 5,591,281 | +8.0% | 0.00% | 0.0% |
| Q2 2021 | $7,299,000 | -4.9% | 5,177,287 | +6.5% | 0.00% | 0.0% |
| Q1 2021 | $7,679,000 | +5.9% | 4,860,585 | +6.6% | 0.00% | 0.0% |
| Q4 2020 | $7,248,000 | -8.4% | 4,558,494 | +0.2% | 0.00% | -50.0% |
| Q3 2020 | $7,912,000 | -9.6% | 4,547,369 | +13.3% | 0.00% | 0.0% |
| Q2 2020 | $8,750,000 | +168.7% | 4,014,105 | +46.6% | 0.00% | +100.0% |
| Q1 2020 | $3,257,000 | -51.6% | 2,737,256 | -44.7% | 0.00% | 0.0% |
| Q4 2019 | $6,728,000 | +114.7% | 4,947,806 | +110.0% | 0.00% | 0.0% |
| Q3 2019 | $3,134,000 | -5.5% | 2,356,480 | +0.2% | 0.00% | 0.0% |
| Q2 2019 | $3,315,000 | -8.7% | 2,351,158 | +7.5% | 0.00% | 0.0% |
| Q1 2019 | $3,631,000 | -4.0% | 2,187,560 | -42.2% | 0.00% | 0.0% |
| Q4 2018 | $3,784,000 | +18.4% | 3,785,112 | +108.4% | 0.00% | 0.0% |
| Q3 2018 | $3,196,000 | -41.9% | 1,816,421 | +13.2% | 0.00% | -50.0% |
| Q2 2018 | $5,505,000 | -9.9% | 1,605,106 | +11.6% | 0.00% | 0.0% |
| Q1 2018 | $6,113,000 | +152.6% | 1,438,408 | +7.0% | 0.00% | +100.0% |
| Q4 2017 | $2,420,000 | -15.9% | 1,344,758 | +1.9% | 0.00% | 0.0% |
| Q3 2017 | $2,876,000 | -20.1% | 1,319,700 | +1.5% | 0.00% | 0.0% |
| Q2 2017 | $3,599,000 | +30.8% | 1,299,615 | +7.2% | 0.00% | 0.0% |
| Q1 2017 | $2,751,000 | +21.7% | 1,212,214 | +11.0% | 0.00% | 0.0% |
| Q4 2016 | $2,260,000 | -11.3% | 1,091,992 | -3.2% | 0.00% | 0.0% |
| Q3 2016 | $2,549,000 | -10.2% | 1,128,571 | +6.6% | 0.00% | -50.0% |
| Q2 2016 | $2,837,000 | -6.4% | 1,058,657 | +1.9% | 0.00% | 0.0% |
| Q1 2016 | $3,032,000 | -38.9% | 1,038,452 | +1.2% | 0.00% | -33.3% |
| Q4 2015 | $4,965,000 | +76.5% | 1,026,020 | +0.7% | 0.00% | +50.0% |
| Q3 2015 | $2,813,000 | -31.3% | 1,019,240 | +6.6% | 0.00% | 0.0% |
| Q2 2015 | $4,093,000 | +17.8% | 956,518 | +3.8% | 0.00% | 0.0% |
| Q1 2015 | $3,475,000 | +20.5% | 921,838 | +3.8% | 0.00% | 0.0% |
| Q4 2014 | $2,885,000 | +65.5% | 887,781 | +1.8% | 0.00% | +100.0% |
| Q3 2014 | $1,743,000 | -37.3% | 871,892 | +0.6% | 0.00% | -50.0% |
| Q2 2014 | $2,781,000 | +63.0% | 866,558 | +5.6% | 0.00% | +100.0% |
| Q1 2014 | $1,706,000 | -42.1% | 820,491 | +32.0% | 0.00% | -50.0% |
| Q4 2013 | $2,947,000 | +51.4% | 621,794 | +7.0% | 0.00% | 0.0% |
| Q3 2013 | $1,946,000 | +146.0% | 580,900 | +10.1% | 0.00% | +100.0% |
| Q2 2013 | $791,000 | – | 527,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 23,375,839 | $49,556,779 | 7.30% |
| MPM BioImpact LLC | 10,712,481 | $22,710,460 | 6.06% |
| Ally Bridge Group (NY) LLC | 2,221,639 | $4,709,875 | 5.53% |
| Vivo Capital, LLC | 16,524,634 | $35,032,224 | 3.84% |
| NEA Management Company, LLC | 22,776,409 | $48,285,987 | 3.73% |
| Deep Track Capital, LP | 25,700,000 | $54,484,000 | 2.10% |
| RA Capital Management | 46,202,425 | $97,949,141 | 1.93% |
| Velan Capital Investment Management LP | 778,500 | $1,650,420 | 1.33% |
| Opaleye Management Inc. | 1,915,000 | $4,059,800 | 1.32% |
| Nan Fung Group Holdings Ltd | 753,550 | $1,597,526 | 1.29% |